Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size

被引:248
|
作者
Morley, R
Carlin, JB
Pasco, JA
Wark, JD
机构
[1] Univ Melbourne, Dept Pediat, Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic 3220, Australia
[4] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia
[5] Univ Melbourne, Royal Melbourne Hosp, Bone & Mineral Serv, Melbourne, Vic 3050, Australia
来源
关键词
D O I
10.1210/jc.2005-1479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: There is inconsistent evidence that maternal 25-hydroxyvitamin D [25-(OH)D] deficiency may impair fetal growth. Objective: The objective of the study was to examine the relationship between maternal 25-(OH) D and PTH concentrations at less than 16 and 28 wk gestation and offspring birth size. Design: This was an observational study. Setting: The study was set at a hospital antenatal clinic. Participants: Women with singleton pregnancies, before 16 wk gestation, participated. Interventions: No interventions were used. Main Outcome Measure: Knee-heel length at birth was the main outcome measure. Results: Altogether 374 of 475 (79%) women completed this study. We found no evident relationship between birth size measures and maternal 25-( OH) D or PTH at recruitment (similar to 11 wk). Gestation length was 0.7 wk (95% confidence interval -1.3, -0.1) shorter and knee-heel length was 4.3 mm smaller (-7.3, -1.3) in infants of 27 mothers with low 25-(OH) D (<28 nmol/liter) at 28-32 wk vs. babies whose mothers had higher concentrations. This latter difference was reduced to -2.7 mm (-5.4, -0.1) after adjustment for gestation length, suggesting some of the apparent growth deficit is explained by shorter gestation. There was no evidence that other birth measures were affected. Maternal PTH concentration at 28-32 wk was positively related to knee-heel length, birth weight, and mid-upper arm and calf circumferences. These associations were independent of 25(OH) D concentration. Conclusions: Low maternal 25-(OH) D in late pregnancy is associated with reduced intrauterine long bone growth and slightly shorter gestation. The long-term consequences for linear growth and health require follow-up. The positive relationship between maternal PTH and measures of infant size may relate to increased mineral demands by larger babies, but warrants further investigation.
引用
收藏
页码:906 / 912
页数:7
相关论文
共 50 条
  • [1] Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification by infant VDR genotype
    R Morley
    J B Carlin
    J A Pasco
    J D Wark
    A-L Ponsonby
    European Journal of Clinical Nutrition, 2009, 63 : 802 - 804
  • [2] Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification by infant VDR genotype
    Morley, R.
    Carlin, J. B.
    Pasco, J. A.
    Wark, J. D.
    Ponsonby, A-L
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2009, 63 (06) : 802 - 804
  • [3] There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase
    R. Vieth
    G. El-Hajj Fuleihan
    Journal of Endocrinological Investigation, 2005, 28 : 183 - 186
  • [4] There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase - Contraopinion
    Vieth, R
    El-Hajj Fuleihan, G
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (02) : 183 - 186
  • [5] Serum Parathyroid Hormone and 25-Hydroxyvitamin D Concentrations Before and After Biliopancreatic Diversion
    Vanessa Tardio
    Jean-Philippe Blais
    Anne-Sophie Julien
    Pierre Douville
    Stefane Lebel
    Laurent Biertho
    Simon Marceau
    Frédéric-Simon Hould
    Claudia Gagnon
    Obesity Surgery, 2018, 28 : 1886 - 1894
  • [6] Serum Parathyroid Hormone and 25-Hydroxyvitamin D Concentrations Before and After Biliopancreatic Diversion
    Tardio, Vanessa
    Blais, Jean-Philippe
    Julien, Anne-Sophie
    Douville, Pierre
    Lebel, Stefane
    Biertho, Laurent
    Marceau, Simon
    Hould, Frederic-Simon
    Gagnon, Claudia
    OBESITY SURGERY, 2018, 28 (07) : 1886 - 1894
  • [7] Association of Leptin, 25-Hydroxyvitamin D, and Parathyroid Hormone in Women
    Maetani, Micah
    Maskarinec, Gertraud
    Franke, Adrian A.
    Cooney, Robert V.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2009, 61 (02): : 225 - 231
  • [8] Parathyroid Hormone to 25-Hydroxyvitamin D: A Cardiometabolic Profile Indicator
    Popovic, D. S.
    Stokic, E.
    Tomic-Naglic, D.
    Vukovic, B.
    Zivanovic, Z.
    Novakovic-Paro, J.
    Mitrovic, M.
    Bajkin, I.
    Ilincic, B.
    Kovacev-Zavisic, B.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (02): : 101 - 104
  • [9] A prospective study of plasma 25-hydroxyvitamin D and parathyroid hormone concentrations and prostate cancer risk
    Deschasaux, Melanie
    Souberbielle, Jean-Claude
    Latino-Martel, Paule
    Sutton, Angela
    Charnaux, Nathalie
    Galan, Pilar
    Hercberg, Serge
    Kesse-Guyot, Emmanuelle
    Ezzedine, Khaled
    Touvier, Mathilde
    ANNALS OF NUTRITION AND METABOLISM, 2015, 67 : 364 - 364
  • [10] Maternal 25-Hydroxyvitamin D and Preterm Birth in Twin Gestations
    Bodnar, Lisa M.
    Rouse, Dwight J.
    Momirova, Valerija
    Peaceman, Alan M.
    Sciscione, Anthony
    Spong, Catherine Y.
    Varner, Michael W.
    Malone, Fergal D.
    Iams, Jay D.
    Mercer, Brian M.
    Thorp, John M., Jr.
    Sorokin, Yoram
    Carpenter, Marshall W.
    Lo, Julie
    Ramin, Susan M.
    Harper, Margaret
    OBSTETRICS AND GYNECOLOGY, 2013, 122 (01): : 91 - 98